Search - tctmd.com

Displaying 261 - 280 of 496

Sort: Relevancy | Date

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Conference News ESC 2014

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Todd Neale

August 30, 2014

News Daily News

Un Meta Análisis Confirma la Ventaja de los SLF de Última Generación en el Manejo de Cuadros de STEMI

Todd Neale

August 07, 2014

News Daily News

Meta-analysis Confirms Advantage of New-Generation DES in STEMI

Todd Neale

August 07, 2014

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Daily News

HOST-ASSURE: Promus Element No es Inferior al Resolute en una Población de Pacientes No Seleccionados

July 10, 2014

News Daily News

HOST-ASSURE：在一般人群中，Promus Element不比Resolute差

July 10, 2014

News Daily News

SCAAR: Menor Riesgo de Trombosis Precoz, Tardía del Stent con Nuevos SLF frente a SMD en el Manejo de Cuadros de STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

Nobori BES Equals Promus Element in Long Lesions

Jason Kahn

May 30, 2014

News Daily News

El SLF Nobori es Similar al Promus Element en el Manejo de Lesiones Largas

Jason Kahn

May 30, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

Yael L. Maxwell

May 23, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Jason Kahn

March 31, 2014

Presentation CIT 2014

XIENCE V China RCT 2 Year Results:A Prospective, Multi-center Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting Stent

Presenter: Gao Runlin

March 22, 2014

News Daily News

ZES Continue to Match EES in All Comers at 4 Years

March 13, 2014

Advertisement

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Un Meta Análisis Confirma la Ventaja de los SLF de Última Generación en el Manejo de Cuadros de STEMI

Meta-analysis Confirms Advantage of New-Generation DES in STEMI

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

HOST-ASSURE: Promus Element No es Inferior al Resolute en una Población de Pacientes No Seleccionados

HOST-ASSURE：在一般人群中，Promus Element不比Resolute差

SCAAR: Menor Riesgo de Trombosis Precoz, Tardía del Stent con Nuevos SLF frente a SMD en el Manejo de Cuadros de STEMI

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Nobori BES Equals Promus Element in Long Lesions

El SLF Nobori es Similar al Promus Element en el Manejo de Lesiones Largas

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

XIENCE V China RCT 2 Year Results:A Prospective, Multi-center Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting Stent

ZES Continue to Match EES in All Comers at 4 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content